Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel L West

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
European Journal of Clinical Pharmacology|March 30, 2024
High refill-adherence to adalimumab is associated with low disease activity in patients with inflammatory bowel diseaseEsma H San, Angelique Egberts, Caroline W Th van Dijck-van Boetzelaer, et al.
Scandinavian Journal of Gastroenterology|January 12, 2010
Impact of double-balloon enteroscopy findings on the management of Crohn's diseasePeter B F Mensink, Huseyin Aktas, Zuzana Zelinkova, et al.
Implementation Science : IS|March 26, 2025
Reporting feedback on healthcare outcomes to improve quality in care: a scoping reviewMariam P Ali, Elyke H Visser, Rachel L West, et al.
European Journal of Gastroenterology & Hepatology|December 25, 2004
Hydrogen peroxide-enhanced three-dimensional endoanal ultrasonography and endoanal magnetic resonance imaging in evaluating perianal fistulas: agreement and patient preferenceRachel L West, Soendersing Dwarkasing, Richelle J F Felt-Bersma, et al.
European Journal of Gastroenterology & Hepatology|August 2, 2021
Re-induction with intravenous Ustekinumab after secondary loss of response is a valid optimization strategy in Crohn's diseaseSebastiaan Ten Bokkel Huinink, Vince Biemans, Marjolijn Duijvestein, et al.
European Journal of Gastroenterology & Hepatology|January 28, 2023
Long-term effectiveness and safety of ustekinumab in Crohn's disease: a prospective cohort studyPepijn W A Thomas, Mark van Caem, Rachel L West, et al.
Gastro Hep Advances|August 12, 2024
Health State Questionnaires Deployed in Ulcerative Colitis Patients: The Medical, Psychological, and Economic PerspectiveDamien S E Broekharst, Pepijn W A Thomas, Maurice G V M Russel, et al.
Digestive Diseases and Sciences|April 17, 2025
Evaluation of an Exercise Program in Patients with Inflammatory Bowel Disease: A Pilot StudyNatasja van de Pol, Elyke H Visser, Desirée van Noord, et al.
Alimentary Pharmacology & Therapeutics|April 28, 2020
A comparative analysis of tioguanine versus low-dose thiopurines combined with allopurinol in inflammatory bowel disease patientsVince B C Biemans, Edo Savelkoul, Ruben Y Gabriëls, et al.
Pharmacoepidemiology and Drug Safety|November 21, 2020
Inflammatory bowel disease patients provide reliable self-reported medical information: A multicentre prospective pharmacovigilance monitoring systemPepijn W A Thomas, Rachel L West, Maurice G V M Russel, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
European Journal of Clinical Pharmacology|March 30, 2024
High refill-adherence to adalimumab is associated with low disease activity in patients with inflammatory bowel diseaseEsma H San, Angelique Egberts, Caroline W Th van Dijck-van Boetzelaer, et al.
Scandinavian Journal of Gastroenterology|January 12, 2010
Impact of double-balloon enteroscopy findings on the management of Crohn's diseasePeter B F Mensink, Huseyin Aktas, Zuzana Zelinkova, et al.
Implementation Science : IS|March 26, 2025
Reporting feedback on healthcare outcomes to improve quality in care: a scoping reviewMariam P Ali, Elyke H Visser, Rachel L West, et al.
European Journal of Gastroenterology & Hepatology|December 25, 2004
Hydrogen peroxide-enhanced three-dimensional endoanal ultrasonography and endoanal magnetic resonance imaging in evaluating perianal fistulas: agreement and patient preferenceRachel L West, Soendersing Dwarkasing, Richelle J F Felt-Bersma, et al.
European Journal of Gastroenterology & Hepatology|August 2, 2021
Re-induction with intravenous Ustekinumab after secondary loss of response is a valid optimization strategy in Crohn's diseaseSebastiaan Ten Bokkel Huinink, Vince Biemans, Marjolijn Duijvestein, et al.
European Journal of Gastroenterology & Hepatology|January 28, 2023
Long-term effectiveness and safety of ustekinumab in Crohn's disease: a prospective cohort studyPepijn W A Thomas, Mark van Caem, Rachel L West, et al.
Gastro Hep Advances|August 12, 2024
Health State Questionnaires Deployed in Ulcerative Colitis Patients: The Medical, Psychological, and Economic PerspectiveDamien S E Broekharst, Pepijn W A Thomas, Maurice G V M Russel, et al.
Digestive Diseases and Sciences|April 17, 2025
Evaluation of an Exercise Program in Patients with Inflammatory Bowel Disease: A Pilot StudyNatasja van de Pol, Elyke H Visser, Desirée van Noord, et al.
Alimentary Pharmacology & Therapeutics|April 28, 2020
A comparative analysis of tioguanine versus low-dose thiopurines combined with allopurinol in inflammatory bowel disease patientsVince B C Biemans, Edo Savelkoul, Ruben Y Gabriëls, et al.
Pharmacoepidemiology and Drug Safety|November 21, 2020
Inflammatory bowel disease patients provide reliable self-reported medical information: A multicentre prospective pharmacovigilance monitoring systemPepijn W A Thomas, Rachel L West, Maurice G V M Russel, et al.
Pageof 6